WallStreetZenWallStreetZen

NYSEMKT: VNRX
Volitionrx Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

VNRX past revenue growth

How has VNRX's revenue growth performed historically?
Company
91.36%
Industry
5.92%
Market
14.15%
VNRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VNRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VNRX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

VNRX earnings and revenue history

Current Revenue
$342.0k
Current Earnings
-$31.4M
Current Profit Margin
-9,185.8%

VNRX Return on Equity

Current Company
-4,402%
Current Industry
-180.9%
Current Market
30.8%
VNRX's Return on Equity (-4,402%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VNRX announces earnings.

VNRX Return on Assets

Current Company
-149.5%
Current Industry
5.6%
VNRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VNRX Return on Capital Employed

Current Company
-3,876.63%
Current Industry
9.8%
VNRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VNRX vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VNRX$341.99k-$30.00M-$31.41M+263.94%N/A
SERA$330.00k-$41.05M-$42.54M+231.66%N/A
MDXHN/AN/AN/AN/AN/A
DRIO$26.66M-$54.20M-$60.29M+35.12%N/A
ENZ$81.12M-$32.58M-$35.24M-5.13%N/A
View Top Diagnostic & Research Stocks

Volitionrx Earnings & Revenue FAQ

What were VNRX's earnings last quarter?

On Invalid Date, Volitionrx (NYSEMKT: VNRX) reported Q1 2023 earnings per share (EPS) of -$0.15, up 7.14% year over year. Total Volitionrx earnings for the quarter were -$8.78 million. In the same quarter last year, Volitionrx's earnings per share (EPS) was -$0.14.

If you're new to stock investing, here's how to buy Volitionrx stock.

What was VNRX's earnings growth in the past year?

As of Q2 2023, Volitionrx's earnings has grown year over year. Volitionrx's earnings in the past year totalled -$31.41 million.

What was VNRX's revenue last quarter?

On Invalid Date, Volitionrx (NYSEMKT: VNRX) reported Q1 2023 revenue of $149.81 thousand up 31.17% year over year. In the same quarter last year, Volitionrx's revenue was $114.21 thousand.

What was VNRX's revenue growth in the past year?

As of Q2 2023, Volitionrx's revenue has grown 91.36% year over year. This is 85.44 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 5.92%. Volitionrx's revenue in the past year totalled $341.99 thousand.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.